| 发明名称 |
Fructose 1,6-bisphosphatase inhibitors |
| 摘要 |
The present invention relates to certain quinazoline compounds which have utility in the treatment of diabetes mellitus, hypercholesterolemia, hyperlipidemia, diabetic complications and cancer. The invention also relates to pharmaceutical compositions and kits comprising such quinazoline compounds and to methods of using such compounds in the treatment of diabetes mellitus, hypercholesterolemia, hyperlipidemia, diabetic complications and cancer.
|
| 申请公布号 |
US2003144308(A1) |
申请公布日期 |
2003.07.31 |
| 申请号 |
US20020251073 |
申请日期 |
2002.09.20 |
| 申请人 |
BAUER PAUL H.;WRIGHT STEPHEN W.;SCHNUR RODNEY C. |
发明人 |
BAUER PAUL H.;WRIGHT STEPHEN W.;SCHNUR RODNEY C. |
| 分类号 |
C07D401/12;C07D403/12;C07D405/12;C07D413/12;C07D417/12;C07D417/14;(IPC1-7):A61K31/541;A61K31/537;A61K31/517;C07D413/14;C0743/02 |
主分类号 |
C07D401/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
